文献速递呼吸道感染

肺组织SARS-CoV-2与流感病毒感染的转录组分析揭示病毒特异性宿主反应与基因特征

Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures.
PubMed 文献 · Eur Respir J · 2022-06-02

本研究利用NanoString GeoMX平台对福尔马林固定石蜡包埋肺组织进行靶向转录组分析,比较COVID-19、大流行H1N1流感和未感染对照患者的肺部转录景观。结果显示COVID-19患者肺中炎症、I型干扰素产生、凝血和血管生成相关基因显著上调,且SARS-CoV-2在肺内分布不均,高病毒载量区域与增强的I型干扰素反应相关。控制细胞类型和患者间变异后,致命流感与COVID-19患者肺间仅极少数基因差异表达,但IFI27在COVID-19肺中显著上调。

要点

  • COVID-19肺组织炎症、I型干扰素、凝血和血管生成基因显著上调。
  • SARS-CoV-2肺内分布不均,高病毒载量区伴增强I型干扰素反应。
  • IFI27在COVID-19肺中较流感患者显著上调,或为鉴别生物标志物。

核心结论

  • 空间转录组学可识别组织内新基因特征,为SARS-CoV-2发病机制提供见解,辅助患者分诊和治疗。

研究设计与样本

  • 利用NanoString GeoMX平台对福尔马林固定石蜡包埋肺组织进行靶向转录组分析,比较COVID-19、大流行H1N1流感和未感染对照患者。

主要发现

  • COVID-19患者肺中炎症、I型干扰素产生、凝血和血管生成相关基因较未感染对照显著上调。
  • SARS-CoV-2在肺内分布不均,高病毒载量区域与增强的I型干扰素反应相关。
  • 控制样本中主导细胞类型、患者内相关性和患者间变异后,致命流感与COVID-19患者肺间仅极少数基因差异表达。
  • IFI27在COVID-19患者肺中较流感患者显著上调。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which emerged in late 2019 has spread globally, causing a pandemic of respiratory illness designated coronavirus disease 2019 (COVID-19). A better definition of the pulmonary host response to SARS-CoV-2 infection is required to understand viral pathogenesis and to validate putative COVID-19 biomarkers that have been proposed in clinical studies. METHODS: Here, we use targeted transcriptomics of formalin-fixed paraffin-embedded tissue using the NanoString GeoMX platform to generate an in-depth picture of the pulmonary transcriptional landscape of COVID-19, pandemic H1N1 influenza and uninfected control patients. RESULTS: Host transcriptomics showed a significant upregulation of genes associated with inflammation, type I interferon production, coagulation and angiogenesis in the lungs of COVID-19 patients compared to non-infected controls. SARS-CoV-2 was non-uniformly distributed in lungs (emphasising the advantages of spatial transcriptomics) with the areas of high viral load associated with an increased type I interferon response. Once the dominant cell type present in the sample, within patient correlations and patient-patient variation, had been controlled for, only a very limited number of genes were differentially expressed between the lungs of fatal influenza and COVID-19 patients. Strikingly, the interferon-associated gene IFI27, previously identified as a useful blood biomarker to differentiate bacterial and viral lung infections, was significantly upregulated in the lungs of COVID-19 patients compared to patients with influenza. CONCLUSION: Collectively, these data demonstrate that spatial transcriptomics is a powerful tool to identify novel gene signatures within tissues, offering new insights into the pathogenesis of SARS-COV-2 to aid in patient triage and treatment.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kulasinghe A, Tan CW, Ribeiro Dos Santos Miggiolaro AF, et al. Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures. Eur Respir J. 2022. PMID: 34675048. doi:10.1183/13993003.01881-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。